First Ascent Biomedical's Functional Precision Oncology bridges that gap by testing living tumor cells to generate actionable data in about 10 days, helping physicians choose the right treatment ...
Enables Whole-Transcriptome In Situ Spatial Biology with Single-Cell Sensitivity at Scale. Debuts at AACR Annual Meeting 2026 ...
Zacks Investment Research on MSN
PacBio & Lucid Genomics partner to boost data analysis, stock up
PacBio PACB recently announced a compatibility collaboration with Lucid Genomics, bringing the latter into its Compatible ...
PacBio (NASDAQ: PACB), a premier developer of sequencing solutions, and Lucid Genomics GmbH, a provider of cutting-edge bioinformatics software for clinical and research genomics, today announced that ...
KNOXVILLE, TN, UNITED STATES, April 7, 2026 /EINPresswire.com/ -- Daisy Genomics Inc. (“Daisy Genomics”), a precision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results